Ifosfamide-based chemotherapy yields high survival rate for treatment of osteosarcoma
Efficacy and safety of ifosfamide-based chemotherapy for osteosarcoma: a meta-analysisDrug Des Devel Ther. 2015 Nov 4;9:5925-32
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
7 randomized controlled trials with 2,529 patients with histologically confirmed osteosarcoma were included in this meta-analysis. The purpose of this study was to compare the safety and efficacy of ifosfamide-based chemotherapy to a control group receiving chemotherapy without ifosfamide. The results displayed that ifosfamide-based chemotherapy had significantly higher event-free survival, overal...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE